By Gia Snape Two recent but consequential federal moves are set to reshape the risk profile of the US cannabis industry.First, an executive order signed by Donald Trump in late 2025 directs federal agencies to advance the long-debated rescheduling of cannabis from a Schedule I to a Schedule III substance.Second, […]